Membranoproliferative Glomerulonephritis including C3 Glomerulopathy Panel

Nephrology

Membranoproliferative Glomerulonephritis including C3 Glomerulopathy Panel

Overview

Test Name
Membranoproliferative Glomerulonephritis including C3 Glomerulopathy Panel
Test Code
NEE1009
Test Category
Gene Panels
Test Subcategory
Nephrology
Disease(s) Targeted
Membranoproliferative glomerulonephritis including C3 glomerulopathy
Who Is The Test For?
Patients with a family history, clinical suspicion, or diagnosis of membranoproliferative glomerulonephritis including C3 glomerulopathy.
Test Approach

Whole exome sequencing (WES) with in silico gene panel analysis.

No. of Genes
8
Panel Content
C3, CFB, CFH, CFHR1, CFHR2, CFHR5, CFI, DGKE
Deliverables
Turnaround Time

~3-6 weeks*

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About Membranoproliferative glomerulonephritis including C3 glomerulopathy

Membranoproliferative glomerulonephritis (MPGN) is a kidney disease characterized by specific injury patterns on a kidney biopsy, including mesangial cell proliferation and thickening of the glomerular basement membrane. The prevalence of MPGN is low, accounting for about 1 to 3% of all kidney biopsy diagnoses. C3 Glomerulopathy (C3G) is a subtype of MPGN caused by a defect in the complement system, a part of the immune system, which results in the deposition of excess C3 protein in the glomeruli. C3G is a complex genetic disorder that is rarely inherited in a simple mendelian fashion. Multiple affected persons within a single nuclear family are reported only occasionally, with both dominant and recessive inheritance being described. There are multiple genes that are associated with C3G, mainly CFH, C3, and CFI, which account for 12%, 11% and 5% of reported cases, respectively.

Gene Panel Workflow

Order a test using our clinical portal

Preview Documents

©2023 Genseq All Rights Reserved.

Terms & Conditions
Privacy Policy
Cookie Policy
Cookie Preferences